Urban Company Ltd Q4 FY2025-26 Earnings Conference Call
Why It Matters
Urban Company's strong growth and margin improvements position it for sustainable profitability, while its cash strength and clear EBITDA targets reassure investors of long‑term value creation.
Key Takeaways
- •Q4 net transaction value surged 42% YoY to 1,148 crores
- •India core services grew 26% with EBITDA margin rising to 3.3%
- •International segment posted 84% Q4 NTV growth, turned EBITDA positive
- •Gaten business scaled 67% Q4, loss narrowed, 75% user retention
- •InstaHealth generated 2.7 M orders, incurring large loss, targeting FY28 break‑even
Summary
Urban Company Ltd reported its FY2025‑26 fourth‑quarter results, marking its strongest order quarter ever and the first full year as a listed company. Net transaction value (NTV) jumped 42% year‑on‑year to 1,148 crores and revenue rose 43% to 426 crores, while the annual transacting user base reached eight million. The core India consumer‑services segment accelerated, delivering 26% NTV growth and improving adjusted EBITDA margin from 1.6% to 3.3%, contributing 131 crores of adjusted EBITDA for the year. International operations in the UAE and Singapore grew 84% in Q4, achieving a positive adjusted EBITDA of 6 crores for FY26, and the Gaten home‑services line expanded 67% with a narrowing loss and 75% repeat‑user rate, far above industry norms.
Management highlighted the rapid scaling of InstaHealth, which logged 2.7 million orders in Q4 and generated 40 crores of NTP, but incurred a 119‑crore adjusted EBITDA loss as the business invests heavily in market‑building, acquisition and supply subsidies. CEO Abhiraad Singh Bhal emphasized the "fastest growth in 11 quarters" and noted that 83% of NTV now comes from retained users, underscoring strong customer stickiness. The company also outlined AI‑driven enhancements across quality control, partner support and demand forecasting, aiming to reduce costs and improve service speed.
Urban Company ended FY26 with 2,021 crores of cash and a clear path to profitability, excluding InstaHealth investments, which already generated 22 crores of adjusted EBITDA in Q4 and 106 crores for the year. The firm reaffirmed its target of consolidated adjusted EBITDA break‑even by Q3 FY28 and a 1,000‑crore adjusted EBITDA run‑rate by FY31. These milestones reflect a disciplined focus on scaling core and international businesses while funding strategic growth in new verticals.
The results signal a turning point for Urban Company, combining high‑velocity top‑line growth with improving margins and a robust balance sheet. Investors can expect continued expansion of the core platform, accelerated international rollout, and a measured path toward overall profitability as the company balances aggressive investment in InstaHealth with cash‑generating operations.
Comments
Want to join the conversation?
Loading comments...